RAB24

Across TCGA pan-cancer cohorts, RAB24 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RAB24 data layer compared with 2 for mutation status and 7 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RAB24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RAB24 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PAAD show a favorable association.

LIHC, ACC, and KICH are the cancer types where RAB24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	All	0.453	0.631	<.001	87	view →
ACC	DFS	Tertile	All	0.261	0.702	<.001	70	view →
KICH	DFS	Median	III,IV	0.269	0.914	<.001	69	view →
UVM	OS	Median	All	0.466	1.000	.003	42	view →
HNSC	OS	Quartile	All	0.807	0.675	.001	37	view →
KIRP	DFS	Tertile	All	0.735	0.907	.005	30	view →
PRAD	DFS	Median	All	0.665	0.928	<.001	26	view →
PAAD	DFS	Median	All	0.372	0.189	.006	23	view →
MESO	OS	Quartile	All	0.881	0.305	.006	21	view →
LGG	DFS	Quartile	All	0.720	0.899	<.001	17	view →
SKCM	OS	Median	All	0.405	0.253	.003	16	view →
CESC	OS	Median	III,IV	0.488	0.817	.005	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RAB24–LIHC (DFS)

Open the LIHC breakdown →